Skip to main content
. 2015 Apr 30;16:103. doi: 10.1186/s12891-015-0555-9

Figure 3.

Figure 3

Effects of anti-TNF-alpha therapy on the levels of progenitor cell phenotypes and clinical severity. ESR, CRP, VAS and progenitor cell phenotypes were measured at baseline and after 3 and 6 months in 8 children with persistently active JIA. In 3 individuals, a blood sample was also performed at 12 months. *p < 0.05 versus baseline.